The role of COX-2 carcinogenesisDANNENBERG, Andrew J; DUBOIS, Raymond N; DUBINETT, Steven M et al.Seminars in oncology. 2004, Vol 31, Num 2, issn 0093-7754, 53 p., SUP7Serial Issue

COX-2 inhibition and lung cancerSANDIER, Alan B; DUBINETT, Steven M.Seminars in oncology. 2004, Vol 31, Num 2, pp 45-52, issn 0093-7754, 8 p., SUP7Article

COX-2 inhibition and colorectal cancerKOEHNE, Claus-Henning; DUBOIS, Raymond N.Seminars in oncology. 2004, Vol 31, Num 2, pp 12-21, issn 0093-7754, 10 p., SUP7Article

COX-2 inhibition in upper aerodigestive tract tumorsALTORKI, Nasser K; SUBBARAMAIAH, Kotha; DANNENBERG, Andrew J et al.Seminars in oncology. 2004, Vol 31, Num 2, pp 30-35, issn 0093-7754, 6 p., SUP7Article

The role of COX-2 inhibition in breast cancer treatment and preventionARUN, Banu; GOSS, Paul.Seminars in oncology. 2004, Vol 31, Num 2, pp 22-29, issn 0093-7754, 8 p., SUP7Article

Multiple roles of COX-2 in tumor angiogenesis: A target for antiangiogenic therapyGATELY, Stephen; LI, William W.Seminars in oncology. 2004, Vol 31, Num 2, pp 2-11, issn 0093-7754, 10 p., SUP7Article

COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancerSABICHI, Anita L; LIPPMAN, Scott M.Seminars in oncology. 2004, Vol 31, Num 2, pp 36-44, issn 0093-7754, 9 p., SUP7Article